Search Results

Viktorija Dorfan and Mette Remø will hold key positions in finance and legal, both reporting directly to the recently appointed CFO, Jon Crowther.

Several new appointments are planned to take effect following the company's transition from public markets in August, including a new CEO, CFO and changes to the board of directors.

Geir Olav Melingen assumed this role the day after the acquisition of the aquaculture genetics firm by Novo Holdings was formalized.

The new CFO was previously Finance Director at the aquaculture genetics firm, having served in the role since the company's formation in 2014.

Dr Ross Houston joined the leading aquaculture genetics firm in 2022, and will now lead global research and development for the newly-independent company.

Announced in November, the sale of Benchmark Holdings' genetics business to life science investment firm Novo Holdings was completed on the last day of March.